Tradestie Institutional Equity Comparison Engine

IRWD vs BGM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IRWD Overall Edge

IRWD Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ironwood Pharmaceuticals, Inc. - Class A (IRWD) driven by superior Valuation, Growth & Margin, Options & Structure while BGM counters with relative strength in Momentum & Technical. Fundamentally, IRWD trades at 12.3x Forward P/E with 62.9% operating margin (+9.0% YoY revenue) versus BGM at N/M Forward P/E and -23.4% operating margin (+69.8% YoY). In options structure, IRWD sits in CONSOLIDATION (30th %ile IV; Dealer Gamma Walls on Pro) against BGM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner IRWD
IRWD 12.3x vs BGM N/M Fwd P/E
Growth & Margin Winner IRWD
Op Margin 62.9% vs -23.4% ยท YoY +9.0% vs +69.8%
Momentum & Technical Winner BGM
1Y +47.8% vs -17.5% ยท 52W Pos 62% vs 74%
Options & Structure Winner IRWD
CONSOLIDATION (30th %ile IV) vs UNCLASSIFIED (N/A IV)
IRWD NASDAQ
Ironwood Pharmaceuticals, Inc. - Class A
Pharmaceutical Preparations
$4.70
-0.21% 1D
Market Cap $779.7M
1M Return +31.65%
1Y Return +47.8%
Forward P/E 12.3x
Unified AI Score
37.8 / 100 SELL
Tech 50.0 Fund 36.0 Flow 67.0 Mom 50.0
BGM NASDAQ
BGM Group Ltd. Class A Ordinary Shares
Pharmaceutical Preparations
$8.00
-1.6% 1D
Market Cap $108.6M
1M Return -21.57%
1Y Return -17.53%
Forward P/E N/M
Unified AI Score
59.6 / 100 HOLD
Tech 65.0 Fund 55.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IRWD +47.8% BGM -17.53% Spread: +53.88 pp (IRWD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IRWD TTM Op. Margin: 62.9% BGM TTM Op. Margin: -23.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IRWD vs BGM. Trailing 12-month operating profitability (IRWD 62.9% vs BGM -23.4%) and valuation multiples (IRWD 12.3x vs BGM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IRWD (6) vs BGM (4)
Institutional Metric IRWD BGM Criterion Row Winner
Market Capitalization Scale $779.7M $108.6M Larger Scale IRWD
Trailing P/E Ratio Valuation 5.2x N/M Lower Multiple IRWD
Forward P/E Ratio Valuation 12.3x N/M Lower Multiple IRWD
Revenue Growth (YoY) Growth +9.0% +69.8% Higher Growth BGM
Operating Margin (TTM) Profitability 62.9% -23.4% Higher Margin IRWD
Net Profit Margin Profitability 37.4% -44.2% Higher Margin IRWD
Return on Equity (ROE) Capital Efficiency -574.7% -7.4% Higher ROE BGM
52-Week Range Position Momentum 62% ($3โ€“$6) 74% ($0โ€“$11) Stronger Trend BGM
Beta / 30D Volatility Risk Regime 1.23ฮฒ ยท 54% Vol 3.69ฮฒ ยท 80% Vol Lower Realized Risk IRWD
Unified Institutional Score Composite Signal 37.8 / 100 (SELL) 59.6 / 100 (HOLD) Higher Composite BGM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IRWD vs BGM Buy Guide
IRWD CONSOLIDATION
138d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 30th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live IRWD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BGM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BGM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IRWD nor BGM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.